Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid

Acta Clinica Croatica

Volumn 47, Issue 1, 2008, Pages 13-18

  Budimir, Jozo ^a   Mihić, Liborija Lugović ^b   Šitum, Mirna ^b   Bulat, Vedrana ^b   Peršić, Sanja ^a   Tomljanović Veselski, Mirna ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c DR JOSIP BEN EVI GENERAL HOSPITAL   (Croatia)

Author keywords

Autoimmune diseases drug therapy; Pemphigoid bullous diagnosis; Pemphigoid bullous therapy; Pemphigus diagnosis; Pemphigus therapy; Skin pathology; Skin diseases, vesiculobullous drug therapy

Indexed keywords

CORTICOSTEROID; DESMOGLEIN; IMMUNOSUPPRESSIVE AGENT;

ADJUVANT THERAPY; ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; BULLOUS PEMPHIGOID; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE PREDISPOSITION; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MIDDLE AGED; MOUTH LESION; MOUTH MUCOSA; PEMPHIGUS VULGARIS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDY; SEX RATIO; SKIN DISEASE; SMOKING; SYMPTOMATOLOGY; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH DISEASES; PEMPHIGOID, BULLOUS; PEMPHIGUS;

EID: 49949110954     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. nd ed., Completely Revised Edition. Fali grad: Springer, 2000.
2. CEKIĆ-ARAMBAŠIN A, et al. Oralna medicina. Zagreb: Školska knjiga, 2005.
3. AMAGAI M. Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol 1996;11:319-52.
4. ASBOE-HANSEN G. Diagnosis of pemphigus. Br J Dermatol 1970;83:81-92.
5. LEVER WF, SCHAUMBURG-LEVER G. Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982. Arch Dermatol 1984;120:44-7.
6. STANLEY JR. Therapy of pemphigus vulgaris. Arch Dermatol 1999;135:76-8.
7. ABERER W, WOLFF-SCHREINER EC, STINGL G, WOLF K. Azathioprine in the treatment of pemphigus vulgaris. A long-term follow up. J Am Acad Dermatol 1987;16:527-33.
8. BYSTRYN JC, STEINMAN NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol 1996;132:203-12.
9. AHMED AR, MAIZE JC, PROVOST TT. Bullous pemphigoid. Clinical immunologic follow-up after successful therapy. Arch Dermatol 1977;113:1043-6.
10. LIU HNH, SU DWP, ROGERS RS III. Clinical variants of pemphigoid. Int J Dermatol 1986; 25:17-27.
11. JUNG M, KIPPES W MESSER G, ZILIKENS D, RZANY B. Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 1999;31:266-8.
12. KORMAN NJ. Bullous pemphigoid. The latest in diagnosis, prognosis, and therapy. Arch Dermatol 1998;134:1137-41.
13. LEVER WF. Pemphigus and pemphigoid. J Am Acad Dermatol 1979;1:2-31.
14. VAILLANT L, HUTTENBERGER B. Acquired bullous diseases of the oral mucosa. Rev Stomatol Chir Maxillofac 2005;106:287-97.
15. PODVINEC M, BUCHNER S, LAMBRECHT T. Highlights from the interdisciplinary consultation for diseases of the mouth in Basel. Ther Umsch 2004;61:295-301.
16. MUTASIM DF. Autoimmune bullous dermatoses in the elderly: diagnosis and management. Drugs Aging 2003;20:663-81.